Marcin Kałużny
age 49Currently 10 roles in 5 KRS entities. In the KRS since 2004.
Roles
| Entity | Role | Since | Address |
|---|---|---|---|
M2k2 sp. z o.o. |
since Apr 23, 2025 | Apr 23, 2025 | ul. Pułtuska 8, 61-052 Poznań |
M2k2 Fortis sp. z o.o. |
since Aug 12, 2025 | Aug 12, 2025 | ul. Pułtuska 8, 61-052 Poznań |
PRO Pharma sp. z o.o. |
since Jul 5, 2022 | Jul 5, 2022 | Pułtuska 8, 61-052 Poznań |
Prosight sp. z o.o. |
since Mar 23, 2015 | Mar 23, 2015 | ul. Janusza Zeylanda 1/8, 60-808 Poznań |
Ulipharma sp. z o.o. |
since Jun 27, 2024 | Jun 27, 2024 | ul. Poznańska 28A, 62-028 Koziegłowy |
Connections graph
Change history
| Date | Event | Details | Entity |
|---|---|---|---|
| Business suspended | President of the Management Board, Partner M2k2 sp. z o.o. | M2k2 sp. z o.o. | |
| Company founded | President of the Management Board, Partner (50% of shares worth PLN 2,500) M2k2 Fortis sp. z o.o. | M2k2 Fortis sp. z o.o. | |
| Company founded | President of the Management Board, Partner (100% of shares worth PLN 5,000) M2k2 sp. z o.o. | M2k2 sp. z o.o. | |
| Company founded | President of the Management Board, Partner (50% of shares worth PLN 2,500) Ulipharma sp. z o.o. | Ulipharma sp. z o.o. | |
| Appointed | Vice President of the Management Board, Partner (50% of shares worth PLN 25,000) PRO Pharma sp. z o.o. | PRO Pharma sp. z o.o. | |
| Left | President of the Management Board, Partner (50% of shares worth PLN 25,000) PRO Pharma sp. z o.o. | PRO Pharma sp. z o.o. | |
| Role changed | Management Board Director → President of the Management Board PRO Pharma sp. z o.o. | PRO Pharma sp. z o.o. | |
| Company founded | President of the Management Board, Partner (50% of shares worth PLN 2,500) Prosight sp. z o.o. | Prosight sp. z o.o. |
Business scale
Total for the entities where the person sat on the management board or held shares, for the years in office.
Signals in related entities
| Signal | Entities |
|---|---|
Bankruptcy or restructuring | None |
Liquidation | None |
Sanctions list | None |
Inactive entity | None |